Meta: Zuckerberg-linked entities sell 27,474 shares

Class B Common Stock is convertible into Class A Common Stock on a 1-for-1 basis, at the holder’s option or upon certain transfers.

Rhea-AI Filing Summary

Meta Platforms, Inc. director and COB and CEO Mark Zuckerberg reported CZI Holdings, LLC’s conversion of 17,140 Class B shares into Class A shares on September 24, 2026; CZI held 100,102,127 Class B shares following the transaction. CZI and Chan Zuckerberg Biohub, Inc. also sold 27,474 Class A shares that day under a Rule 10b5-1 trading plan adopted by Zuckerberg on January 31, 2026.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 22 txns

Insider Zuckerberg Mark

Role COB and CEO

Sold 27,474 shs ($21.36M)

Approx. gross sale proceeds $21.36M

Type	Security	Shares	Price	Value
Conversion	Class B Common Stock F15, F1	17,140	$0.00	$0.00
Conversion	Class A Common Stock F1	17,140	$0.00	$0.00
Sale	Class A Common Stock F2, F3, F1	2,093	$775.3906	$1.62M
Sale	Class A Common Stock F2, F4, F1	2,516	$776.5564	$1.95M
Sale	Class A Common Stock F2, F5, F1	7,607	$777.6303	$5.92M
Sale	Class A Common Stock F2, F6, F1	4,324	$778.3554	$3.37M
Sale	Class A Common Stock F2, F7, F1	600	$779.3263	$468K
Sale	Class A Common Stock F8, F9, F10	1,133	$775.3185	$878K
Sale	Class A Common Stock F8, F11, F10	1,769	$776.5624	$1.37M
Sale	Class A Common Stock F8, F12, F10	4,810	$777.6616	$3.74M
Sale	Class A Common Stock F8, F13, F10	2,146	$778.3993	$1.67M
Sale	Class A Common Stock F8, F14, F10	476	$779.2765	$371K
holding	Class B Common Stock F15, F16	--	--	--
holding	Class B Common Stock F15, F17	--	--	--
holding	Class B Common Stock F15, F18	--	--	--
holding	Class B Common Stock F15, F19	--	--	--
holding	Class B Common Stock F15, F20	--	--	--
holding	Class B Common Stock F15, F21	--	--	--
holding	Class B Common Stock F15, F22	--	--	--
holding	Class B Common Stock F15, F23	--	--	--
holding	Class B Common Stock F15, F24	--	--	--
holding	Class B Common Stock F15, F25	--	--	--

Holdings After Transaction: Class B Common Stock — 100,102,127 contracts (Indirect, By CZI Holdings, LLC); Class A Common Stock — 0 shares (Indirect, By CZI Holdings, LLC); Class A Common Stock — 1,220,703 shares (Indirect, By Chan Zuckerberg Biohub, Inc.); Class B Common Stock — 3,388,097 contracts (Indirect, By Mark Zuckerberg, Trustee Of The Mark Zuckerberg Trust Dated July 7, 2006); Class B Common Stock — 17,061,801 contracts (Indirect, By Chan Zuckerberg Holdings, LLC); Class B Common Stock — 12,000,000 contracts (Indirect, By CZI Holdings I, LLC); Class B Common Stock — 8,663,023 contracts (Indirect, By Chan Zuckerberg Holdings II, LLC); Class B Common Stock — 50,000,000 contracts (Indirect, By Chan Zuckerberg Holdings III, LLC); Class B Common Stock — 100 contracts (Indirect, CZ Management, LLC); Class B Common Stock — 50,000,000 contracts (Indirect, By Chan Zuckerberg Holdings IV, LLC); Class B Common Stock — 50,000,000 contracts (Indirect, By Chan Zuckerberg Holdings V, LLC); Class B Common Stock — 40,000,000 contracts (Indirect, By Chan Zuckerberg Holdings VI, LLC); Class B Common Stock — 10,000,000 contracts (Indirect, By Chan Zuckerberg Holdings A LLC)

Footnotes (25)

1. F1. Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.
2. F2. The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.
3. F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. F7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. F8. The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.
9. F9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. F10. Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.
11. F11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
12. F12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
13. F13. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
14. F14. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
15. F15. The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.
16. F16. Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.
17. F17. Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.
18. F18. Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.
19. F19. Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.
20. F20. Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.
21. F21. Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.
22. F22. Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.
23. F23. Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.
24. F24. Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.
25. F25. Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

Key Figures

Class A shares sold: 27,474 shares Class B shares converted: 17,140 shares Class B shares held following conversion: 100,102,127 shares +2 more

5 metrics

Class A shares sold 27,474 shares CZI Holdings, LLC and Chan Zuckerberg Biohub, Inc.; September 24, 2026

Class B shares converted 17,140 shares Converted into Class A shares by CZI Holdings, LLC on September 24, 2026

Class B shares held following conversion 100,102,127 shares CZI Holdings, LLC; September 24, 2026

Weighted average sale price $775.3906 per share CZI Holdings, LLC sale of 2,093 Class A shares

Weighted average sale price $775.3185 per share Chan Zuckerberg Biohub, Inc. sale of 1,133 Class A shares

Key Terms

Rule 10b5-1 trading plan, weighted average price, convertible, pecuniary interest

4 terms

Rule 10b5-1 trading plan regulatory

"pursuant to the Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The reported price in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

convertible financial

"Class B Common Stock is convertible into the issuer’s Class A Common Stock"

A convertible is a type of investment that starts as a loan or preferred stake (like a bond or preferred share) but can be exchanged for common shares of the company at a set price or under certain conditions. It matters to investors because it offers a mix of steady income and downside protection like a loan, plus the upside of stock ownership if the company does well—similar to holding a coupon that you can trade for a full ticket if the event becomes valuable.

pecuniary interest financial

"has no pecuniary interest in these shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many META shares were sold on September 24, 2026?

CZI Holdings, LLC and Chan Zuckerberg Biohub, Inc. sold 27,474 Class A shares on September 24, 2026.

What can META Class B shares convert into?

Class B Common Stock is convertible into the issuer’s Class A Common Stock on a 1-for-1 basis at the holder’s option or upon certain transfers, and has no expiration date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 07:48 PM Accepted by SEC EDGAR 09/28/2026 - 07:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zuckerberg Mark

(Last) (First) (Middle)

C/O META PLATFORMS, INC.

1 META WAY

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Meta Platforms, Inc. [ META ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	COB and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/24/2026		C		17,140	A	$0	17,140	I	By CZI Holdings, LLC(1)
Class A Common Stock	09/24/2026		S(2)		2,093	D	$775.3906(3)	15,047	I	By CZI Holdings, LLC(1)
Class A Common Stock	09/24/2026		S(2)		2,516	D	$776.5564(4)	12,531	I	By CZI Holdings, LLC(1)
Class A Common Stock	09/24/2026		S(2)		7,607	D	$777.6303(5)	4,924	I	By CZI Holdings, LLC(1)
Class A Common Stock	09/24/2026		S(2)		4,324	D	$778.3554(6)	600	I	By CZI Holdings, LLC(1)
Class A Common Stock	09/24/2026		S(2)		600	D	$779.3263(7)	0	I	By CZI Holdings, LLC(1)
Class A Common Stock	09/24/2026		S(8)		1,133	D	$775.3185(9)	1,229,904	I	By Chan Zuckerberg Biohub, Inc.(10)
Class A Common Stock	09/24/2026		S(8)		1,769	D	$776.5624(11)	1,228,135	I	By Chan Zuckerberg Biohub, Inc.(10)
Class A Common Stock	09/24/2026		S(8)		4,810	D	$777.6616(12)	1,223,325	I	By Chan Zuckerberg Biohub, Inc.(10)
Class A Common Stock	09/24/2026		S(8)		2,146	D	$778.3993(13)	1,221,179	I	By Chan Zuckerberg Biohub, Inc.(10)
Class A Common Stock	09/24/2026		S(8)		476	D	$779.2765(14)	1,220,703	I	By Chan Zuckerberg Biohub, Inc.(10)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock(15)	(15)	09/24/2026		C			17,140	(15)	(15)	Class A Common Stock	17,140	$0	100,102,127	I	By CZI Holdings, LLC(1)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	3,388,097		3,388,097	I	By Mark Zuckerberg, Trustee Of The Mark Zuckerberg Trust Dated July 7, 2006(16)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	17,061,801		17,061,801	I	By Chan Zuckerberg Holdings, LLC(17)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	12,000,000		12,000,000	I	By CZI Holdings I, LLC(18)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	8,663,023		8,663,023	I	By Chan Zuckerberg Holdings II, LLC(19)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	50,000,000		50,000,000	I	By Chan Zuckerberg Holdings III, LLC(20)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	100		100	I	CZ Management, LLC(21)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	50,000,000		50,000,000	I	By Chan Zuckerberg Holdings IV, LLC(22)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	50,000,000		50,000,000	I	By Chan Zuckerberg Holdings V, LLC(23)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	40,000,000		40,000,000	I	By Chan Zuckerberg Holdings VI, LLC(24)
Class B Common Stock(15)	(15)							(15)	(15)	Class A Common Stock	10,000,000		10,000,000	I	By Chan Zuckerberg Holdings A LLC(25)

Explanation of Responses:

1. Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

2. The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

8. The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026.

9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

10. Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares.

11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

13. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

14. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

15. The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

16. Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

17. Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

18. Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

19. Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

20. Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

21. Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

22. Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

23. Shares held of record by Chan Zuckerberg Holdings V, LLC ("CZ Holdings V"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings V.

24. Shares held of record by Chan Zuckerberg Holdings VI, LLC ("CZ Holdings VI"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings VI.

25. Shares held of record by Chan Zuckerberg Holdings A LLC ("CZ Holdings A"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings A.

	/s/ Erin Guldiken, attorney-in-fact for Mark Zuckerberg	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)